questionsmedicales.fr
Troubles mentaux
Troubles neurocognitifs
Démence
Démence : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Démence : Questions médicales les plus fréquentes",
"headline": "Démence : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Démence : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-13",
"dateModified": "2025-02-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Démence"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles neurocognitifs",
"url": "https://questionsmedicales.fr/mesh/D019965",
"about": {
"@type": "MedicalCondition",
"name": "Troubles neurocognitifs",
"code": {
"@type": "MedicalCode",
"code": "D019965",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Démence associée au SIDA",
"alternateName": "AIDS Dementia Complex",
"url": "https://questionsmedicales.fr/mesh/D015526",
"about": {
"@type": "MedicalCondition",
"name": "Démence associée au SIDA",
"code": {
"@type": "MedicalCode",
"code": "D015526",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie d'Alzheimer",
"alternateName": "Alzheimer Disease",
"url": "https://questionsmedicales.fr/mesh/D000544",
"about": {
"@type": "MedicalCondition",
"name": "Maladie d'Alzheimer",
"code": {
"@type": "MedicalCode",
"code": "D000544",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aphasie progressive primaire",
"alternateName": "Aphasia, Primary Progressive",
"url": "https://questionsmedicales.fr/mesh/D018888",
"about": {
"@type": "MedicalCondition",
"name": "Aphasie progressive primaire",
"code": {
"@type": "MedicalCode",
"code": "D018888",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Creutzfeldt-Jakob",
"alternateName": "Creutzfeldt-Jakob Syndrome",
"url": "https://questionsmedicales.fr/mesh/D007562",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Creutzfeldt-Jakob",
"code": {
"@type": "MedicalCode",
"code": "D007562",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Démence vasculaire",
"alternateName": "Dementia, Vascular",
"url": "https://questionsmedicales.fr/mesh/D015140",
"about": {
"@type": "MedicalCondition",
"name": "Démence vasculaire",
"code": {
"@type": "MedicalCode",
"code": "D015140",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.350"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Démence par infarctus multiples",
"alternateName": "Dementia, Multi-Infarct",
"url": "https://questionsmedicales.fr/mesh/D015161",
"about": {
"@type": "MedicalCondition",
"name": "Démence par infarctus multiples",
"code": {
"@type": "MedicalCode",
"code": "D015161",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.350.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Kosaka-Shibayama",
"alternateName": "Diffuse Neurofibrillary Tangles with Calcification",
"url": "https://questionsmedicales.fr/mesh/D055956",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Kosaka-Shibayama",
"code": {
"@type": "MedicalCode",
"code": "D055956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.370"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dégénérescence lobaire frontotemporale",
"alternateName": "Frontotemporal Lobar Degeneration",
"url": "https://questionsmedicales.fr/mesh/D057174",
"about": {
"@type": "MedicalCondition",
"name": "Dégénérescence lobaire frontotemporale",
"code": {
"@type": "MedicalCode",
"code": "D057174",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Démence frontotemporale",
"alternateName": "Frontotemporal Dementia",
"url": "https://questionsmedicales.fr/mesh/D057180",
"about": {
"@type": "MedicalCondition",
"name": "Démence frontotemporale",
"code": {
"@type": "MedicalCode",
"code": "D057180",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380.299"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Démence de Pick",
"alternateName": "Pick Disease of the Brain",
"url": "https://questionsmedicales.fr/mesh/D020774",
"about": {
"@type": "MedicalCondition",
"name": "Démence de Pick",
"code": {
"@type": "MedicalCode",
"code": "D020774",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380.299.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Démence de Pick",
"alternateName": "Pick Disease of the Brain",
"url": "https://questionsmedicales.fr/mesh/D020774",
"about": {
"@type": "MedicalCondition",
"name": "Démence de Pick",
"code": {
"@type": "MedicalCode",
"code": "D020774",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380.299.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aphasie primaire progressive non fluente",
"alternateName": "Primary Progressive Nonfluent Aphasia",
"url": "https://questionsmedicales.fr/mesh/D057178",
"about": {
"@type": "MedicalCondition",
"name": "Aphasie primaire progressive non fluente",
"code": {
"@type": "MedicalCode",
"code": "D057178",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.380.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Huntington",
"alternateName": "Huntington Disease",
"url": "https://questionsmedicales.fr/mesh/D006816",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Huntington",
"code": {
"@type": "MedicalCode",
"code": "D006816",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Klüver-Bucy",
"alternateName": "Kluver-Bucy Syndrome",
"url": "https://questionsmedicales.fr/mesh/D020232",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Klüver-Bucy",
"code": {
"@type": "MedicalCode",
"code": "D020232",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.431"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie à corps de Lewy",
"alternateName": "Lewy Body Disease",
"url": "https://questionsmedicales.fr/mesh/D020961",
"about": {
"@type": "MedicalCondition",
"name": "Maladie à corps de Lewy",
"code": {
"@type": "MedicalCode",
"code": "D020961",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.512"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Démences mixtes",
"alternateName": "Mixed Dementias",
"url": "https://questionsmedicales.fr/mesh/D000093902",
"about": {
"@type": "MedicalCondition",
"name": "Démences mixtes",
"code": {
"@type": "MedicalCode",
"code": "D000093902",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.615.400.756"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Démence",
"alternateName": "Dementia",
"code": {
"@type": "MedicalCode",
"code": "D003704",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Birgit Teichmann",
"url": "https://questionsmedicales.fr/author/Birgit%20Teichmann",
"affiliation": {
"@type": "Organization",
"name": "Network Aging Research, Heidelberg University, Heidelberg, Germany."
}
},
{
"@type": "Person",
"name": "Amy Pepper",
"url": "https://questionsmedicales.fr/author/Amy%20Pepper",
"affiliation": {
"@type": "Organization",
"name": "Admiral Nurse Research Assistant, Dementia UK."
}
},
{
"@type": "Person",
"name": "Magda Tsolaki",
"url": "https://questionsmedicales.fr/author/Magda%20Tsolaki",
"affiliation": {
"@type": "Organization",
"name": "Greek Association of Alzheimer's Disease and Related Disorders (GAADRD), Thessaloniki, Greece."
}
},
{
"@type": "Person",
"name": "Nicole Darlington",
"url": "https://questionsmedicales.fr/author/Nicole%20Darlington",
"affiliation": {
"@type": "Organization",
"name": "Centre for Research in Public Health and Community Care, 3769University of Hertfordshire, Hertfordshire, UK."
}
},
{
"@type": "Person",
"name": "Michael Woodward",
"url": "https://questionsmedicales.fr/author/Michael%20Woodward",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health Sciences, 83726University of East Anglia, Norwich, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Computerized cognitive and social cognition training in schizophrenia for impulsive aggression.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36424289",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.schres.2022.11.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Treatment preferences among adults with normal cognition and cognitive impairment.",
"datePublished": "2022-09-12",
"url": "https://questionsmedicales.fr/article/36094330",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jgs.18032"
}
},
{
"@type": "ScholarlyArticle",
"name": "Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.",
"datePublished": "2023-01-09",
"url": "https://questionsmedicales.fr/article/36634906",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neuroscience.2023.01.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deep Cognitive Gate: Resembling Human Cognition for Saliency Detection.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/33755558",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1109/TPAMI.2021.3068277"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of cognitive stimulation program on cognition and mood in older adults, stratified by cognitive levels: A randomized controlled trial.",
"datePublished": "2023-03-04",
"url": "https://questionsmedicales.fr/article/36921506",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.archger.2023.104984"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles neurocognitifs",
"item": "https://questionsmedicales.fr/mesh/D019965"
},
{
"@type": "ListItem",
"position": 4,
"name": "Démence",
"item": "https://questionsmedicales.fr/mesh/D003704"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Démence - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Démence",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Démence",
"description": "Comment diagnostique-t-on la démence ?\nQuels tests sont utilisés pour diagnostiquer la démence ?\nLa démence peut-elle être confondue avec d'autres maladies ?\nQuels signes précoces indiquent une démence ?\nQui peut poser le diagnostic de démence ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Cognition&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Démence",
"description": "Quels sont les symptômes courants de la démence ?\nLa démence affecte-t-elle le langage ?\nLes hallucinations sont-elles un symptôme de démence ?\nComment la démence affecte-t-elle le comportement ?\nLes troubles du sommeil sont-ils liés à la démence ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Cognition&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Démence",
"description": "Peut-on prévenir la démence ?\nQuel rôle joue l'exercice physique dans la prévention ?\nL'alimentation méditerranéenne aide-t-elle à prévenir la démence ?\nLa stimulation cognitive est-elle bénéfique ?\nLe contrôle des facteurs de risque cardiovasculaires est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Cognition&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Démence",
"description": "Quels traitements existent pour la démence ?\nLes médicaments peuvent-ils ralentir la progression de la démence ?\nQuelles thérapies non médicamenteuses sont efficaces ?\nLes soins palliatifs sont-ils une option pour les patients ?\nComment la famille peut-elle aider un proche atteint de démence ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Cognition&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Démence",
"description": "Quelles complications peuvent survenir avec la démence ?\nLa démence augmente-t-elle le risque de dépression ?\nComment la démence affecte-t-elle la nutrition ?\nLes comportements agressifs sont-ils une complication ?\nLa démence peut-elle entraîner des problèmes de mobilité ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Cognition&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Démence",
"description": "Quels sont les principaux facteurs de risque de démence ?\nLe diabète est-il un facteur de risque pour la démence ?\nLe tabagisme influence-t-il le risque de démence ?\nLe niveau d'éducation joue-t-il un rôle ?\nLes traumatismes crâniens augmentent-ils le risque de démence ?",
"url": "https://questionsmedicales.fr/mesh/D003704?mesh_terms=Cognition&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la démence ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique, des tests cognitifs et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour diagnostiquer la démence ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests neuropsychologiques, des bilans sanguins et des IRM peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La démence peut-elle être confondue avec d'autres maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme la dépression ou les troubles thyroïdiens peuvent simuler des symptômes."
}
},
{
"@type": "Question",
"name": "Quels signes précoces indiquent une démence ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des oublis fréquents, des difficultés à se concentrer et des changements de comportement."
}
},
{
"@type": "Question",
"name": "Qui peut poser le diagnostic de démence ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un médecin généraliste, un neurologue ou un gériatre peut établir le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la démence ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la perte de mémoire, la confusion, et des changements d'humeur."
}
},
{
"@type": "Question",
"name": "La démence affecte-t-elle le langage ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes peuvent avoir des difficultés à trouver les mots ou à suivre une conversation."
}
},
{
"@type": "Question",
"name": "Les hallucinations sont-elles un symptôme de démence ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de démence, comme la démence à corps de Lewy, peuvent provoquer des hallucinations."
}
},
{
"@type": "Question",
"name": "Comment la démence affecte-t-elle le comportement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des changements de personnalité, de l'agitation ou de l'apathie."
}
},
{
"@type": "Question",
"name": "Les troubles du sommeil sont-ils liés à la démence ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles du sommeil sont fréquents chez les personnes atteintes de démence."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la démence ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que l'exercice, une alimentation saine et la stimulation cognitive peuvent aider."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut améliorer la santé cérébrale et réduire le risque de démence."
}
},
{
"@type": "Question",
"name": "L'alimentation méditerranéenne aide-t-elle à prévenir la démence ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cette alimentation riche en fruits, légumes et oméga-3 est associée à un risque réduit."
}
},
{
"@type": "Question",
"name": "La stimulation cognitive est-elle bénéfique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des activités comme la lecture, les puzzles et les jeux de société peuvent aider."
}
},
{
"@type": "Question",
"name": "Le contrôle des facteurs de risque cardiovasculaires est-il important ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, gérer l'hypertension, le diabète et le cholestérol peut réduire le risque de démence."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour la démence ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments pour gérer les symptômes et des thérapies non médicamenteuses."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils ralentir la progression de la démence ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent ralentir la progression, mais ils ne guérissent pas la maladie."
}
},
{
"@type": "Question",
"name": "Quelles thérapies non médicamenteuses sont efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie occupationnelle, la musicothérapie et les activités sociales peuvent aider."
}
},
{
"@type": "Question",
"name": "Les soins palliatifs sont-ils une option pour les patients ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les soins palliatifs peuvent améliorer la qualité de vie en fin de vie."
}
},
{
"@type": "Question",
"name": "Comment la famille peut-elle aider un proche atteint de démence ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La famille peut offrir un soutien émotionnel, aider à la gestion des soins et à la communication."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la démence ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des chutes et des problèmes nutritionnels."
}
},
{
"@type": "Question",
"name": "La démence augmente-t-elle le risque de dépression ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de démence sont plus susceptibles de développer une dépression."
}
},
{
"@type": "Question",
"name": "Comment la démence affecte-t-elle la nutrition ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes peuvent avoir des difficultés à manger, entraînant une malnutrition."
}
},
{
"@type": "Question",
"name": "Les comportements agressifs sont-ils une complication ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer des comportements agressifs ou agités."
}
},
{
"@type": "Question",
"name": "La démence peut-elle entraîner des problèmes de mobilité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la démence peut affecter la coordination et l'équilibre, augmentant le risque de chutes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de démence ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les antécédents familiaux et les maladies cardiovasculaires sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque pour la démence ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète mal contrôlé augmente le risque de développer une démence."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque de démence ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de démence et de déclin cognitif."
}
},
{
"@type": "Question",
"name": "Le niveau d'éducation joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un niveau d'éducation plus élevé est souvent associé à un risque réduit de démence."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens augmentent-ils le risque de démence ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traumatismes crâniens répétés peuvent augmenter le risque de démence à long terme."
}
}
]
}
]
}
Schizophrenia is associated with an elevated risk for impulsive aggression for which there are few psychosocial treatment options. Neurocognitive and social cognitive deficits have been associated wit...
The two-center study randomized 130 participants to receive 36 sessions of either a combination of cognitive remediation and social cognition treatment or cognitive remediation plus a computer-based c...
Study participants were mostly male (84.5 %), had a mean age 34.9 years, and 11.5 years of education. Both Cognitive Remediation Training (CRT) plus Social Cognition Training (SCT) and CRT plus contro...
CRT proved to be an effective non-pharmacological treatment in reducing impulsive aggression in schizophrenia inpatient participants with a history of aggressive episodes. The addition of social cogni...
Although patient participation in treatment decisions is important for preference-concordant care delivery, it is largely unknown how cognitive impairment influences treatment preferences. We investig...
Data from the 2018 Health and Retirement Study were used. The sample included 1291 self-respondents (201 respondents with cognitive impairment, and 1090 with normal cognition). We examined treatment p...
Respondents with cognitive impairment were more likely to report that they were unsure about treatment options across both clinical scenarios compared to those with normal cognition. For the limited t...
Compared to those with normal cognition, cognitive impairment was associated with greater uncertainty about treatment preferences and higher rates of aggressive care preferences among those who specif...
Subjective cognitive decline (SCD) and objective subtle cognitive difficulties (Obj-SCD) are considered the initial stages of aberrant cognition prior to mild cognitive impairment (MCI) due to Alzheim...
Saliency detection by human refers to the ability to identify pertinent information using our perceptive and cognitive capabilities. While human perception is attracted by visual stimuli, our cognitiv...
Cognitive stimulation (CS) is defined as activities that involve cognitive processing, usually conducted in a social context and often in a group. This study aims to evaluate the effects of a personal...
The randomized controlled single-blind trial involving 337 participants (235 women and 102 men) ≥ 65 years of age in a Primary Care centre classified participants into 4 groups: 101 for the no deterio...
The intervention showed a tendency of improvement on global cognition and different cognitive functions for groups with no deterioration or level deterioration. The group with moderate deterioration i...
The findings demonstrated benefits in global cognition, different cognitive functions, semantic fluency, IADLs and anxiety. The most benefits are given in the intermediate groups, SCI, and LD. Moreove...
The Montreal Cognitive Assessment (MoCA) was developed as a screening tool for mild cognitive impairment (MCI). Given the need for a rapid screening test in settings such as primary care, we compare t...
Cross-sectional study involving community-dwelling 'old' (65 to 79 years old) and 'old-old' (≥ 80 years old) without dementia. Cognitive impairment was defined by MoCA score 17 to 22. Validation was d...
Of the 183 participants (mean age 72.1 ± 5.2 years),15.8% (n = 29) were classified as cognitively impaired. The overall ROC curve had an AUC of 0.82 (95% CI 0.75-0.90, P < 0.01) with an optimal cut-of...
The three-item RCS is quick and easy to administer. Although RCS met the criterion for good validity against MoCA in predicting cognitive impairment, its utility as a first-line screening tool needs t...
In this paper, we propose a crucial supplement to the framework of plant cognition, namely extend...
Subjective cognitive decline (SCD) is a self-reported cognitive decline without objective cognitive impairment. The relationship between audiometric hearing loss (HL) and cognitive function has not be...
This is a cross-sectional study that used the baseline data of a multicenter cohort study that monitors clinical progression from SCD to dementia. Individuals aged ≥60 years who reported cognitive dec...
Of a total of 120 participants, one hundred and two had NH (n = 57) or bilateral HL (n = 45). There were no group differences in the demographic and clinical data except the age. The biomarkers, globa...
In SCD, HL exerted an adverse effect on cognitive function, primarily frontal executive function tested in the Stroop task. HL was also related to gray matter volume reductions in brain subregions, al...
Physical and cognitive function are both indicators of aging, characterized by a loss of adaptive response to life challenges and functional limitations, subsequently affecting their quality of life. ...
The study participants were 79 older adults recruited from community centers in four urban districts of Korea. All participants completed a self-reported questionnaire for demographic characteristics ...
The mean age of participants was 77.46 years old with an elementary or lower education level (53.2%). The mean score of cognitive function was 16.39 (SD = 6.5). Physical function (grip strength, balan...
In conclusion, physical and cognitive function were significant predictors of QOL in older adults with cognitive impairment. Specifically, balance has significant indirect effects on the physical comp...
Both Alzheimer's disease (AD) genetic risk factors and indices of cognitive reserve (CR) influence risk of cognitive decline, but it remains unclear whether they interact. This study examined whether ...
Analyses used data from the Preclinical AD Consortium, including harmonized data from 5 longitudinal cohort studies. Participants were cognitively normal at baseline (M baseline age = 64 years, 59% fe...
In mixed-effects models, higher CR index scores were associated with better baseline cognitive performance for all cognitive outcomes. APOE-ε4 genotype and AD-PRS that included the APOE region (AD-PRS...
These results suggest that APOE-ε4 and non-APOE-ε4 AD polygenic risk are independently associated with global cognitive and executive function declines among individuals with normal cognition at basel...